peripheral artery disease
Conditions
Interventions
None listed
Sponsors
Saiseikai Yokohama City Eastern Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with stenotic or arteriosclerosis obliterans with superficial femoral artery lesions (Rutherford classification 2-6). However, acute (within 7 days) and subacute (within 1 month) lower limb ischemia cases are excluded. (2) Age: 20 years or older (at the time of EVT treatment for femoral popliteal artery lesions) (3)Gender: No matter (4) Patients who can be observed for at least 12 months after EVT (5)Patients who underwent EVT for femoral popliteal artery lesions between July 1, 2017 and June 30, 2020
Exclusion criteria
Exclusion criteria: (1)Patients who are bleeding or have a tendency to bleed (Hemophilia, capillary fragility, intracranial hemorrhage, gastrointestinal hemorrhage, urinary tract bleeding, hemoptysis, etc.) (2)Pregnant women or patients who may be pregnant (3)Patients with acute / subacute lower limb ischemia (4) Patients with a life expectancy of 1 year or less (5)Patients who have difficulty in going to the hospital due to referral from a distance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary patency | — |
Secondary
| Measure | Time frame |
|---|---|
| TLR: target lesion revascularization MACLE: MACE(major adverse cardiovascular event)+MALE(major adverse limb event) | — |
Countries
Japan
Contacts
Public ContactShinsuke Mori
Saiseikai Yokohama City Eastern Hospital Cardiology
Outcome results
None listed